AZD8205, PACLITAXEL, DOXORUBICIN
D6900C00003
Phase 3 small_molecule active
Quick answer
AZD8205, PACLITAXEL, DOXORUBICIN for B7-H4-Selected Advanced/Metastatic Endometrial Cancer. is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- B7-H4-Selected Advanced/Metastatic Endometrial Cancer.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active